Biosensor Markets Rising To $27.06 Billion By 2022

A research report "Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food & Beverages Industry), Technology, Product (Wearable and Non-Wearable), and Geography - Global Forecast to 2022", published by MarketsandMarkets, claims the market is expected to be valued at USD 27.06 Billion by 2022, growing at a CAGR of 8.84% between 2017 and 2022.

The market growth is driven by the continuous technological advancements in the biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in the demand for glucose monitoring systems. 

  • Point-of-care applications held the largest size of the biosensors market in 2016
  • Glucose monitoring to hold the largest share of the biosensors market for point-of-care applications by 2022
  • The market in APAC expected to grow at a high rate between 2017 and 2022

Some of the major players operating in the biosensors market include Abbott Point of Care Inc. (US), Medtronic, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (US), LifeSensors Inc. (US), Nova Biomedical Corp. (US), Acon Laboratories Inc. (US), Universal Biosensors (Australia), Pharmaco-Kinesis Corporation (PKC) (US), Bayer Healthcare AG (Germany), Biacore (UK), Bio-Rad Laboratories Inc. (US), Biosensors International Ltd. (Singapore), Ercon, Inc. (US), DuPont (US), and Sysmex Corporation (Japan).

Browse 73 market data Tables and 86 Figures spread through 182 Pages and in-depth TOC on "Biosensors Market" at

Early buyers will receive 10% customization on this  report.


Seattle, WA


[email protected]